Quoin Pharmaceuticals Ltd
NASDAQ:QNRX
Cash Flow Statement
Cash Flow Statement
Quoin Pharmaceuticals Ltd
| Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||||||||||
| Net Income |
(6)
|
(6)
|
(5)
|
(4)
|
(5)
|
(4)
|
(6)
|
(5)
|
(5)
|
(8)
|
(10)
|
(11)
|
(21)
|
(19)
|
(18)
|
(19)
|
(9)
|
(10)
|
(10)
|
(9)
|
(9)
|
(8)
|
(8)
|
(9)
|
(9)
|
(10)
|
(12)
|
(14)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Other Non-Cash Items |
(1)
|
(1)
|
(3)
|
(3)
|
(1)
|
(1)
|
2
|
2
|
1
|
4
|
6
|
6
|
14
|
11
|
8
|
8
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
0
|
1
|
0
|
(0)
|
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
(1)
|
(1)
|
(0)
|
0
|
0
|
2
|
|
| Cash from Operating Activities |
(7)
N/A
|
(7)
-3%
|
(7)
-3%
|
(7)
+5%
|
(6)
+15%
|
(4)
+21%
|
(4)
+6%
|
(4)
+11%
|
(5)
-20%
|
(4)
+8%
|
(4)
+4%
|
(4)
+1%
|
(6)
-45%
|
(7)
-29%
|
(8)
-13%
|
(10)
-17%
|
(8)
+13%
|
(8)
+4%
|
(8)
+7%
|
(7)
+13%
|
(8)
-19%
|
(8)
+4%
|
(8)
-6%
|
(9)
-11%
|
(8)
+11%
|
(9)
-15%
|
(11)
-19%
|
(11)
0%
|
|
| Investing Cash Flow | |||||||||||||||||||||||||||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Items |
4
|
3
|
3
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(10)
|
(10)
|
(13)
|
(10)
|
(0)
|
2
|
1
|
1
|
4
|
(2)
|
5
|
4
|
4
|
|
| Cash from Investing Activities |
4
N/A
|
3
-33%
|
2
-5%
|
(0)
N/A
|
(0)
+37%
|
0
N/A
|
0
N/A
|
(0)
N/A
|
(0)
-155%
|
(0)
-180%
|
(0)
-53%
|
(0)
-18%
|
(1)
-48%
|
(1)
+15%
|
(1)
-14%
|
(10)
-1 612%
|
(10)
+2%
|
(14)
-34%
|
(10)
+24%
|
(0)
+96%
|
2
N/A
|
1
-45%
|
1
+10%
|
4
+195%
|
(2)
N/A
|
5
N/A
|
4
-28%
|
4
-2%
|
|
| Financing Cash Flow | |||||||||||||||||||||||||||||
| Net Issuance of Common Stock |
4
|
7
|
6
|
7
|
6
|
2
|
4
|
4
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
6
|
6
|
6
|
5
|
5
|
5
|
12
|
6
|
6
|
6
|
|
| Net Issuance of Debt |
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
1
|
3
|
3
|
3
|
2
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Other |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
10
|
10
|
10
|
25
|
15
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
4
N/A
|
7
+87%
|
6
-4%
|
6
+1%
|
6
-5%
|
2
-68%
|
4
+84%
|
4
-1%
|
4
+10%
|
3
-33%
|
3
+26%
|
3
-1%
|
14
+315%
|
12
-11%
|
10
-18%
|
25
+149%
|
14
-43%
|
20
+42%
|
20
+0%
|
5
-75%
|
5
+5%
|
5
-8%
|
5
-1%
|
5
+3%
|
11
+126%
|
6
-48%
|
6
0%
|
6
0%
|
|
| Change in Cash | |||||||||||||||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Change in Cash |
1
N/A
|
3
+122%
|
2
-32%
|
(0)
N/A
|
0
N/A
|
(3)
N/A
|
(1)
+70%
|
(0)
+68%
|
(0)
-37%
|
(2)
-439%
|
(1)
+40%
|
(1)
-5%
|
7
N/A
|
4
-43%
|
1
-76%
|
5
+375%
|
(5)
N/A
|
(2)
+61%
|
2
N/A
|
(2)
N/A
|
(0)
+78%
|
(2)
-235%
|
(2)
-24%
|
(0)
+98%
|
1
N/A
|
2
+63%
|
(1)
N/A
|
(1)
-9%
|
|
| Free Cash Flow | |||||||||||||||||||||||||||||
| Free Cash Flow |
(7)
N/A
|
(7)
-3%
|
(7)
-3%
|
(7)
+6%
|
(6)
+15%
|
(4)
+22%
|
(4)
+6%
|
(4)
+11%
|
(5)
-22%
|
(4)
+4%
|
(4)
+1%
|
(4)
-1%
|
(6)
-44%
|
(8)
-25%
|
(9)
-13%
|
(10)
-14%
|
(9)
+15%
|
(8)
+5%
|
(8)
+9%
|
(7)
+13%
|
(8)
-19%
|
(8)
+4%
|
(8)
-6%
|
(9)
-11%
|
(8)
+11%
|
(9)
-15%
|
(11)
-19%
|
(11)
0%
|
|